The reproductive system of human female exhibits a much faster rate of aging than other body systems. Ovarian aging is thought to be dominated by a gradual decreasing numbers of follicles, coinciding with diminished quality of oocytes. Menopause is the final step in the process of ovarian aging. This review focuses on the mechanisms underlying the ovarian aging involving a poor complement of follicles at birth and a high rate of attrition each month, as well as the alternated endocrine factors. We also discuss the possible causative factors that contribute to ovarian aging, e.g., genetic factors, accumulation of irreparable damage of microenvironment, pathological effect and other factors. The appropriate and reliable methods to assess ovarian aging, such as quantification of follicles, endocrine measurement and genetic testing have also been discussed. Increased knowledge of the ovarian aging mechanisms may improve the prevention of premature ovarian failure. The ovary undergoes much more serious effects of age than any other tissues of the body, and the reproductive outcome has been demonstrated to be negatively correlated with age [1,2]. The ovarian aging related follicle number reduction and oocyte quality decay cause the gradual decline in fertility and ultimately natural sterility. Thus, "poor ovarian reserve (OR)" is often used synonymously with "ovarian aging". The variability of ovarian aging among individuals is evident indicated by the large variable age at menopause. This implies that some females remain fertile until the fifth decade of life, which is physiological ovarian aging, whereas others face the loss of natural fertility in their mid-thirties, which is called premature ovarian failure (POF), and is pathological ovarian aging. The mechanisms behind gradual decreasing of the follicle pool and the decaying oocyte quality are far from being totally understood, although some progress involved in the endocrine, paracrine, metabolic and genetic factors has given some light to the complex puzzle.
The ovary undergoes much more serious effects of age than any other tissues of the body, and the reproductive outcome has been demonstrated to be negatively correlated with age [1,2]. The ovarian aging related follicle number reduction and oocyte quality decay cause the gradual decline in fertility and ultimately natural sterility. Thus, "poor ovarian reserve (OR)" is often used synonymously with "ovarian aging".
The variability of ovarian aging among individuals is evident indicated by the large variable age at menopause. This implies that some females remain fertile until the fifth decade of life, which is physiological ovarian aging, whereas others face the loss of natural fertility in their mid-thirties, which is called premature ovarian failure (POF), and is pathological ovarian aging. The mechanisms behind gradual decreasing of the follicle pool and the decaying oocyte quality are far from being totally understood, although some progress involved in the endocrine, paracrine, metabolic and genetic factors has given some light to the complex puzzle.
Mechanisms underlying ovarian aging
During human fetal life, germ cells rapidly proliferate by mitosis to reach a maximum of 67 million oocytes by 1620 weeks of pregnancy in human beings [3, 4] . Formation of primordial follicles occurs in fetal ovaries by the late second trimester. Once the pool of primordial follicles formed, it serves as a source of developing follicles [3, 5, 6] , and the primordial follicles in the pool remain quiescent for many years (even for 40 years) until activated to become primary follicles [6] . Every month, a few follicles from this pool are activated and progress through the stages of primary, preantral and antral follicle. Eventually, only one follicle (dominant follicle) reaches the pre-ovulatory stage while the others undergo atresia at different developmental stages [3, 7] . Simultaneously, the number of oocytes undergoes an inevitable decline. At birth, approximately 12 mil-
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lion follicles are present in ovary [8] , and 300000500000 remain by the onset of puberty [9, 10] . During the reproductive years of life, the number of primordial follicles decreases at a steady rate of approximate 1000 follicles per month [1113] . Actually, more than 99.9% of primordial follicles undergo atresia at different developing stages and only about 400-500 follicles reach ovulation stage in the lifetime [11] .
Follicle loss and ovary aging
Ovarian aging is thought to be dominated by a gradual decrease in the number of primordial follicles. With ovarian aging, oocyte quality reduces with the increased incidence of miscarriages and chromosomal aberrations that usually occur after the age of 35 years [9, 12, 14, 15] (Figure 1) .
The accelerating decline of follicle pool is ascribed to a poor complement of follicles at birth and/or a high rate of attrition each month. The variation of ovarian aging among individuals is considerable. Some women show a bi-exponential decline, i.e., an abrupt decline at 38 years of age [16] , while others favor an exponential decline throughout reproductive life [17] . At about 31 years old, fecundity begins gradually decreasing and the number of follicles could fall below the critical level of 25000 at approximately 37.5 years of age, indicating the beginning of the ovarian aging [13, 18] . The decline in ovarian follicle pool dictates the onset of important reproductive processes, including decaying fecundity, natural infertility, irregular menstrual cycle and ultimately menopause [19] . The final menstrual period (menopause) occurs at an average age of 51 years [20] , when only about 1000 follicles remain in the ovaries [13] .
As the decrease in follicle numbers, the quality of oocyte also diminishes. The decay of oocyte quality is believed to be owing to an increase in meiotic nondisjunction, leading to an increasing rate of aneuploidy in the early embryo of older females [2124] , and also to many other factors (Figure 1) . Underlying mechanisms may involve differences between germ cells when they are formed, accumulated damages in oocytes during the lifetime, or age-related decay of the quality of the granulosa cells surrounding the oocyte [9, 25] .
A study of European women who lived between the16th and the early 19th century showed that those who married late more likely to be infertile，women who married when older than 35 years of age had twice the chance of sterility compared with those who married at 3034 years of age [26] . Hence, delayed childbearing increases the chance of Figure 1 Schematic representation of the number of primordial follicles present in the ovaries and the quality of oocytes in relation to female age. The graph is modified from Hansen et al. [5] and de Bruin et al. [19] .
failure of spontaneous pregnancy [26] . Delayed childbearing and reduced age-related natural sterility have resulted in an increase in the number and proportion of women more than 35 years of age who need to receive ART (assisted reproductive technologies) treatment [11] . Unfortunately, the ART treatment outcomes are also adversely influenced by advanced patient age, and to optimize treatment outcomes for these patients becomes more and more critical [27] . These indicate that the decreased quantity and quality of follicles contribute to the fertility decline.
Follicle loss and endocrine
Ovary, also as an important endocrinal organ, secrets sex hormones and preserves the normal menstrual cycle cooperating with hypothalamus and pituitarium. The number of the follicles in ovary has a direct relationship with the menstrual cycle during peri-menopausal stages, interacting with the levels of progesterone and gonadotropin (FSH and LH). Epidemiologic studies in women show that hormones change at both the individual and population levels [20] , and these studies extend our understanding of some key hormonal changes which occur during female reproductive aging. During the period of the transition from peri-menopausal to menopause, the number of follicles falls sharply as a result of follicle recruitment accelerating and the loss of the residual follicular stock speeding up [18] , which are caused by the rising of FSH level [11, 28] . As a result, the length of the menstrual cycle could be shortened as well as follicular phase [3, 29, 30] . The primary clinical sign of the reproductive aging is that the length of the menstrual cycle is shortened by 2-3 d [3, 31] .
The increase of FSH level is caused by declining inhibin B and AMH which are negative regulators of FSH level [11] . The main sources of inhibin B and AMH are the pre-antral and small antral follicles [3234] . The depletion of the premature follicles along with aging leads to low level of inhibin B and AMH [3540] , and concurrently results in FSH accumulation [4143] . Increasing FSH level accelerates the processes of selection and recruitment of the dominant follicles. Meanwhile, high level FSH impels granulosa cells around premature oocytes undergoing untimely maturity. The non-synchronous maturation between granulosa cells and oocytes results in more follicular atresia and loss [11, 18, 44] . As the FSH level increasing, the courses mentioned above could be magnified until the primordial follicle pool exhausted, estrogen level reduced, ultimately menopause [45, 46] . The changes of endocrine contribute to a series of menopause symptoms caused by ovary aging and many age-related diseases, such as cardiovascular disease, osteoporosis, Alzheimer's disease, cancer, and obesity.
Factors that cause ovary aging
In general, factors affecting oocyte quality and quantity with the age are still not well defined. However, several risk factors have been indicated to be associated with premature ovarian aging and consequently the age at menopause (Figure 1) , such as genetic factors, microenvironment factors and pathological factors and other factors [47] .
Genetic factors

Genomic DNA alternation
The role of genetic factors concerning "menopausal age" has attracted increasing attention in recent years. Family history of premature menopause has been convincingly certified [4850]. Through the menopausal age observations in sibling pairs and parent-child comparisons, it is generally accepted that genetic factors must be involved in the processes directing reproductive aging. the heritability has been estimated to range from 30% to 85% [51] .
POF is an ovarian defect that the primordial follicle pool depletes before the age of 40 years, which can be defined as a type of ovarian aging. Therefore, POF may offer a unique model for the insights into the genetic mechanisms of ovarian aging. Several mutant mouse models such as GDF9 [57] , and one gene in the linkage of chromosome 9 encodes a member of BCL2 family, which is participated in apoptosis [58, 59] . Besides, a number of highly significant associations with menopausal age have been demonstrated for SNPs in regions on chromosomes 5, 6, 13, 19, and 20 by genome-wide association study in several natural menopause cohorts [60, 61] .
In addition, the incidence of aneuploidy increases with the age. Pellestor et al. [62, 63] have indicated the relationship between maternal age and chromosomal abnormalities based on the research in 1397 human oocytes obtained from IVF treatment cycles. This cytogenetic study demonstrated that chromosome non-disjunction contributed to the occurrence of aneuploidy during either meiosis I or II [64] . The occurrence of non-disjunction has been attributed to the abnormal chromosomal alignment, meiotic spindle defects or reduced formation of chiasmata [6568] . Meanwhile, according to Angell et al. [69] , the cohesins that hold the chromatids together during metaphase I decline gradually but constantly with age in female, which contributes to the premature separation of chromatids during meiosis and finally results in aneuploidy. In summary, both the nondisjunction and the premature separation of chromosomes contribute to aneuploidy during either meiosis I or II [70, 71] .
Mitochondrial DNA (mtDNA) mutation
Mitochondria play a key role in energy production, cell proliferation and apoptosis. Their own genetic material, mtDNA, is maternally inherited. mtDNA is very important, in spite of its smaller size compared with genomics DNA. Trifunovic et al. [72] engineered mutant polgA knock-in mice with a defect in the nucleus-encoded catalytic subunit of mtDNA polymerase. These mice develop a premature aging phenotype beginning at 9 months because of the accumulated mtDNA mutations. Their work provides a causative relationship between mtDNA mutations and aging phenotypes in mammals. According to the observation on luteinizing granulosa cells, Seifer et al. showed that these somatic cells contain higher levels of mtDNA deletion in the women ages >38 years [73] , and deeply reduced antioxidant enzymes in the damage mitochondria [74] , and facilitate the activation of the apoptosis in oocytes, by providing specific factors such as ceramide [75, 76] . Seifer et al. [76] showed that the mtDNA 4977-bp deletion (△mtDNA 4977 ) increased in the older women, which may affect the fertilization. Hamatani et al. [56] showed different expression of mitochondrial function genes that participated in the ATP metabolism and binding, as well as many other genes involved in the ubiquitin-proteasome and NF-kappa B pathway based on comparing the young and old oocyte. In abnormal mitochondria, [Ca 2+ ] oscillations fail to trigger ATP production which support normal physiological processes [77, 78] , such as spindle formation, abnormal chromosomal alignment [65, 79] , and then affect fertility. However, these abnormalities can be rescued by micro-injecting cytoplasm from younger oocytes [80] . In short, mitochondria sustain the normal physiological functions of ovary through the ATP synthesis, calcium signaling and apoptosis.
Decreased telomerase activity
Currently, the correlation between reproduction and telomere length has received growing attractions. Telomeres are the repetitive DNA sequences at chromosomal ends, which cap the chromosomes and prevent end-to-end fusion of chromosomes [81, 82] . The telomere length is a marker for cellular aging as it gradually shortens with successive cell division. Once telomeres reach a threshold length, cell cycle arrest, apoptosis and genomic instability will ensure [81, 83, 84] . Telomerase can maintain the telomere length and therefore ensures genomic stability [8587]. The telomerase deficiency, combined with long-time exposure to ROS, may lead to the telomere shortening quickly, which will affect maternal aging on fertility [88] . Kinugawa et al. [89] indicated that the telomerase activity was present in the young ovaries, but it decreased with age. They speculated that the primordial follicle depletion was related to the decline of telomerase activity, so the telomerase maybe used as a marker of ovarian functional age. Hanna et al. [90] believed that longer telomere in the POF patients may be related to slow cell division rates or abnormal hormone exposure in these women. Butts et al. [91] considered that the aberrant telomere homeostasis was due to occult ovarian insufficiency in young women. Hamatani et al. [56] noted that the expression of TERT (telomerase reverse transcriptase) decreased during general aging and cellular senescence. In conclusion, old oocytes may be unable to maintain intact chromosomes due to the low telomerase activity, which affects the female fertility.
Microenvironment factors in the ovarian aging
Oxidative stress (OS) and ovarian aging
Till now, research on aging causative factors is mainly focusing on the spontaneous damages accumulated during daily biological metabolism process [92, 93] . The modification of different kinds of molecules caused by oxidative stress is suggested to be one of the culprits of aging [94] .
Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are called free radicals and have high reactivity [95] , which are generated during the biological metabolism process. The widely accepted theory is that the aging-associated cellular respiratory decline can result in increased intra-mitochondrion electron leakage and raised production of ROS, which in turn affect mtDNA stability and the function of mitochondria [96, 97] . When the generation of pro-oxidants including ROS and RNS exceeds the scavenging capacity by antioxidants, the oxidative stress (OS) appears. This imbalance could cause extensive oxidative damages which then induce cytochrome c and other apoptosis trigger factors release from mitochondria and finally result in cell death [98100].
Since the increase in ROS production during aging may lead to oxidized proteins accumulation, the free-SH protein level was used to explain the relationship between the intracellular oxidative stress and ovarian aging by Tatone et al. [100] . Their results clearly demonstrated a remarkable quantitative and qualitative decrease in free-SH protein in ovarian follicular fluid especially in older women. The decrease of free-SH protein with age strongly suggests that an increase of oxidative stress in the follicular microenvironment with aging [100] . Based on the same principle, Wiener-Megnazi et al. [101] reported an age-related increase in free radical activity which also correlates with a low success rate of IVF by the ROS level quantification. Thus, it is be-lieved that higher oxidative stress presents in follicular fluid of older women.
Long-lasting higher oxidative stress damage is considered to be involved in the process of ovarian aging [102, 103] . An investigation between poor oocyte quality and oxidative stress indicated that women undergoing IVF have a significantly higher concentration of 8-OHdG (a marker of DNA oxidation degree) in the ovarian follicular fluid and a similar higher proportion of degenerative oocytes. Whereas providing those women who failed to become pregnant in the IVF-embryo transfer trial with antioxidants results in an obviously reduced intrafollicular concentration of 8-OHdG and higher pregnant rate [104] . Recent studies have also shown that age-related decay of oocytes accompany with dysfunction of mitochondria. This adverse change arises from excessive free radicals. Mitochondrial dysfunction can cause cellular injury that increased with age [105, 106] . Together with an age-related estrogen decrease, the loss of its protective effects against oxidative stress finally lead to decay of the ovary. It may account for the significantly elevated rate of congenital birth defects in the women older than 38 years [107] .
Over the past few years, several studies in mammas indicated that long-term age-related oxidative stress was caused by the impairment of antioxidant enzymatic defense. Tarin et al. [108] described a sharp decrease of glutathione (GSH) and glutathione transferase (GST), both of which are involved in free radical scavenging, in ovulated mature oocytes from aged mice. It has been found that administration of antioxidants to reproductively old mice effectively rescued the adverse effects of female aging on oocyte quality [109] . Others suggested that oxidative stress level in young mouse oocytes negatively affects spindle structure by decreasing ATP production, thus give a good mimic model of the aging process [110] . Similarly, such a pattern of enzymatic defense is obviously affected by reproductive aging as oocytes from older women have a reduced ratio between CAT (catalase) and SOD (superoxide dismutase), indicating a decrease of ROS scavenging capability with aging [111, 112] . The weakening of antioxidant defense also occurs in granulosa cells where reproductive aging accompanies with the down regulation of Cu/Zn SOD, Mn SOD, CAT, and accumulation of oxidative damages [111] .
These results indicate that oxidative stress has a negative impact on oocyte development. With the accumulation of oxidative damage through increase in ROS production and a contemporaneous lowering of antioxidant defense will finally lead to pathological ovarian aging.
AGEs and ovarian aging
The formation of AGEs (advanced glycation end products) is an irreversible process, accelerating with aging, atherosclerosis, diabetes mellitus, etc. Long-lived proteins such as collagens, nerve proteins, and lens crystallins are most vulnerable to be affected by AGEs [113] . It was suggested that AGEs cause tissue injury either through protein crosslinking or directly binding to specific receptors termed RAGE (receptor for advanced glycation end-products) located in different cells, such as endothelium and smooth muscle cells [114] . For example, AGEs deposited in the arterial wall in Alzheimer patients may induce oxidant stress to promote further damage [115117], as well as irreversible cross-linked proteins in vessel collagen which finally contributes to atherosclerosis [118] . Frye et al. [119] have demonstrated that the concentration of cross-links in collagen and lens proteins increased with aging in AGEs-dependent manner. The binding of AGE with their specific receptors RAGE would result in generation of intracellular oxidative stress [114] . By using different AGE inhibitors researchers found that blocking the formation of AGEs in experimental animals prevents or slows down aging [120, 121] . Tatone et al. also observed that the expression and activity of enzymes for detoxifying methylglyoxal, a major precursor of AGEs, in ovaries of reproductively old mice are lower than in young mice. All the above observations indicated that the accumulation of AGEs in aging ovary and other age-related diseases is a marked event, they may account for weakened efficiency of vascularization and for the activation of oxidative response through RAGE interaction.
Perifollicular vascularization and ovarian aging
It is suggested that a healthy microenvironment is essential for follicular development and oocyte quality. An important aspect of effects is oxygen supply and paracrine regulators that are mainly supplied by perifollicular vascularization [122124] . Indeed, modifications such as spindle and chromosome abnormalities are similar between young oocytes obtained from Graafian follicles with reduced perifollicular vascularization and old MII oocytes [108, 125] . Unlike primordial and preantral follicles which gain their blood supply mainly from the stromal vessels, growing follicles depend on an ingrowth of capillaries into the theca [77] . It was well known that dominant follicles have more blood vessel than others [126, 127] , and oocytes deriving from follicles with complete vascularization and plenteous oxygen content (3%) had higher fertilization and developmental potential [128] . Furthermore, studies of perifollicular vascularity before oocyte aspiration demonstrated a positive correlation between high-grade vascularity and improved live birth rate during IVF [129, 130] . The hypoxia due to an inadequate ingrowth of capillaries into the theca of the mature follicle may trigger an oxidative stress. It is further supported by the observation that mitochondria of granulosa cells from aged women exhibit structural damage similar to those found in other cells with a hypoxia treatment [74, 131] .
In a word, the reduced oxygen content, nutritional factors, signaling molecules and others in aged ovary depending on a compromised perifollicular vascularization are typical characteristics of ovarian aging.
Pathological effects
Ovarian pathological changes may contribute to subfertility. Endometriosis is a disease that functioning endometrial tissue is outside the uterine cavity. Endometriosis is the foremost disease of reproductive-age women, 30%50% of patients with endometriosis are infertility. Research has found that endometriosis was significantly related to age, peaking at ages 4044 [132] . Laparoscopic excision or ablation lesions helps to improve pregnancy rate in patients with mild or moderate endometriosis [133] . However, excision of endometriotic ovarian cysts decreased the ovarian sensitivity to gonadotropin [134] . More evidences are needed to illustrate the effects of these coexisting diseases on ovarian function. This also reminds us that surgical exploration of infertile patients needs more cautions.
Other factoring
Epidemiological investigations revealed that the ovarian function would be affected by environmental, behavioral and other factors. From the 1980s onwards, a successive epidemiological survey suggested that educational level, occupation and contraceptives have effects on ovarian function and fertility [135] . Smoking is also known to advance menopause [136] . Long-term exposure to smoking has been shown to be associated with subfertility of women in later life [137] . However, the exact mechanism underlying is yet unknown. Ovarian aging is also associated with the exposure to radiation, heavy metals, pesticides and chemicals which could perturb the meiotic process and cause aneuploidy [138] . In addition, improper diet can also promote premature ovarian aging [139] .
Ovarian aging assessment
In assisted reproductive technology (ART), ovarian aging has become a major detrimental factor of pregnancy achievement and maintenance. Thus, accurate assessment of ovarian aging is of utmost importance. Currently, in order to measure ovarian aging, a variety of tests have been developed (Figure 1 ).
Quantification of follicles
Ovarian aging in woman is thought to be dominated by a gradual decreasing numbers of follicles, coinciding with diminished quality of the oocytes within the follicles [9] . Total ovarian reserve (TOR) contains primordial follicles (not growing follicles, NGFs) and early growing follicles (GFs), thus the assessment of TOR could reflect the ovarian condition and predict menopausal age.
Theoretically, the most direct representation of the ovarian reserve (OR) is the quantity of ovarian NGFs. The number of primordial follicles in the peri-menopausal ovaries are only about 1/10 of that in the ovaries with the regular menstrual cycles, and primordial follicles are hardly found in postmenopausal ovaries [140] . Ovarian biopsy from 60 infertile women aged 1945 years showed a significant negative correlation between age and follicular density and ovarian volume [141] . However, the follicle density within the cortex has been shown to vary greatly in the same ovary and the minimum number of follicles required for fertility are also unknown [107, 142] , invasive ovarian biopsy was concluded not to be a reliable test of OR.
Currently, noninvasive and available ultrasound tests of ovarian aging include AFC (antral follicle count), ovarian volume and ovarian blood flow. Some reports showed that AFC was found to have a better reliability than ovarian volume to predict ovarian response during ART [143] . In recent years, AFC has been demonstrated to be correlated with the occurrence of the menopausal transition [144] , and to be related strongly with the quantitative aspects of OR. Considering the ease of measurement, low cost and reliability, AFC has become one of the most commonly used ultrasonic markers of ovarian reserve in clinical practice [145] . In woman with poor ovarian reserve, stromal blood flow has been shown to be reduced or absent by Doppler assessment [146] . It is possible that ovarian stromal flow is used in the prediction of premature ovarian aging.
Endocrine measurement
Ovarian is an endocrine organ and functions through the feedback of gonadal hormones and gonadotropins. The decreased size of AFC is the main cause of the altered feedback, with a reduction in inhibin B secretion in the initial stages and estradiol and inhibin A output in later stages. This serological testing method is convenient and with high reproducibility.
During the early follicular phase, basal hormone tests including serum follicle-stimulating hormone (FSH), E2 and FSH/luteinizing hormone (LH) ratio, have been traditionally employed for OR assessment. The elevated FSH level is an irrefutable sign of ovarian aging, which only rise 10 years before the menopause or when women are becoming infertile. Therefore, the change of FSH level is only a short-term predictor [147, 148] . The levels of estradiol and inhibin A remain stable in early follicular phase in women, until the later phase of the menopausal transition [149, 150] . Thus, the predictive ability of these tests to ovarian aging is limited in some extents.
Anti-mullerian hormone (AMH) and inhibin are the TGF-B (transforming growth factor-B) superfamily members. AMH is secreted into serum preferentially by small antral follicles [151, 152] . Previous studies have shown that the AMH level is strongly related to inhibin B, FSH and AFC in IVF [153, 154] . With the decrease in the number of AFC, the AMH serum level diminishes as well [144,155157] . In contrast to other markers, one of the main advantages of AMH is the stability of its serum level during the entire menstrual cycle [158] . Therefore, in clinical practice, AMH seems to be a suitable marker for OR prediction [159] . Nevertheless, serum AMH levels would invariably become undetectable near menopause [160] and this low-value makes it difficult to predict menopause age accurately.
Inhibin B is primarily produced by antral follicles which are FSH-sensitive [161, 162] . A reduction in cohort size with aging is accompanied by elevated FSH levels and decreased inhibin B secretion [163] , however, inhibin B is often viewed as a rather late marker of decreased follicle numbers [43, 163] .
Genetic testing
Increasing attention has been paid to the genetic factors of ovarian aging and natural menopausal age. The high heritability for the age of menopause indicates that there is a genetic effect in ovarian aging [9] . Genes whose alteration causes POF have also been used for the assessment of ovarian aging. These genes are those that associated with primordial follicle formation and growth, such as FIGLA, BMP15 and GDF9 gene [164, 165] , and those involved in hormone production, such as FSHR, LHR, FSH, CYP19 and CYP17 [164, 165] . As the substantial advances in genome research and its applications to the field of reproduction, genetic diagnosis of ovarian aging will become more popular.
Perspective
The mechanism underlying ovarian aging is exceptionally complex. It has been known that the OR is decreasing over time, but how this reserve is established in fetal ovaries, and whether the germline stem cells exist, are still unknown. With the continuous development of science and technology, transgenic/knockout technology and gene chips could be used to study the intrinsic molecular mechanisms of ovarian aging. Proper assessment of ovarian aging is of utmost importance. The diagnosis of predictability at appropriate timing may guide pregnancy achievement or fertility preservation in women at risk. 
